Articles

New meta-analysis striving to expand on the notion that glycemic control and stroke risk are closely associated.

Sotagliflozin to be reviewed by the FDA as possible oral adjunct for people with insulin-treated type 1 diabetes.

Discrepancies prompt additional analyses of ACCORD-BP and SPRINT studies to determine best blood pressure target for those with diabetes.

Detection of euglycemic ketoacidosis could be a challenge for physicians since this condition can mask an underlying diabetic ketoacidosis.

With more than 8 trillion text messages sent worldwide every year, self-management support for blood glucose (SMS4BG) has potential to help improve glycemic management of patients who have diabetes.

Data from DIAMOND trial to help determine if CGM helps those with consistently high glucose.

Elevated BP readings at the doctor’s office linked to higher mortality than for those with consistently normal blood pressure.

Use of expanded criteria thought best way to detect widest population with abnormal blood glucose levels.

It can improve insulin sensitivity, pancreatic response to blood sugars, and even prevent prediabetes from turning into diabetes.

ADA Guidelines highlight importance of social stability in diabetes management.